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a b s t r a c t 
S. aureus is a leading cause of bacterial infection. Macrophages, the first line of defence in the human 
immune response, phagocytose and kill S. aureus but the pathogen can evade these responses. Therefore, 
the exact role of macrophages is incompletely defined. We develop a mathematical model of macrophage 
- S. aureus dynamics, built on recent experimental data. We demonstrate that, while macrophages may 
not clear infection, they significantly delay its growth and potentially buy time for recruitment of further 
cells. We find that macrophage killing is a major obstacle to controlling infection and ingestion capacity 
also limits the response. We find bistability such that the infection can be limited at low doses. Our 
combination of experimental data, mathematical analysis and model fitting provide important insights in 
to the early stages of S. aureus infections, showing macrophages play an important role limiting bacterial 
replication but can be overwhelmed with large inocula. 
© 2020 The Authors. Published by Elsevier Ltd. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
1. Introduction 
S. aureus is a major cause of both community-acquired and 
hospital-acquired infections, causing a broad spectrum of disease 
ranging from skin and soft tissue infections to bacteraemia and 
infection of prosthetic devices ( Cole et al., 2014 ). The pathogen 
contributes significantly to infection-related mortality and health- 
associated costs ( de Kraker et al., 2011 ). Part of its success stems 
from a range of pathogen adaptations that subvert host defence 
( Cole et al., 2014 ). In addition it is resistant to a range of an- 
timicrobials and virulent methicillin resistant strains of S. aureus 
(MRSA) have become a major health problem in many settings 
( DeLeo et al., 2010 ). 
Macrophages are the resident phagocytes in tissues and play 
critical roles in host defense as the first professional phagocyte 
to encounter bacteria at sites of infection ( Dockrell et al., 2003 ). 
Traditionally S. aureus has been classified as an extracellular bac- 
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terium that is readily phagocytosed and killed by phagocytes. Tis- 
sue macrophages are sufficient to clear S. aureus in murine mod- 
els of pulmonary infection where mice are rendered neutropenic 
( Rehm et al., 1980 ), illustrating the potential role they can play in 
initial pathogen control at sites of infection. S. aureus is efficiently 
phagocytosed by macrophages ( Jonsson et al., 1985 ). It is well es- 
tablished that S. aureus can avoid a range of innate immune re- 
sponses from recognition to intracellular killing ( Rooijakkers et al., 
2006 , Richardson et al., 2008 ) and this aids pathogenicity. In 
particular S. aureus employs several adaptations to resist oxida- 
tive stress and other microbicidal strategies utilised by phagocytes 
( Cole et al., 2014 ). We have recently demonstrated that differen- 
tiated macrophages, that model tissue macrophages such as the 
alveolar macrophage resident in the lung, although competent for 
bacterial clearance, have a finite capacity for intracellular killing, 
which is the rate limiting step in pathogen clearance ( Jubrail et al., 
2015 ). 
Mechanistic mathematical models can be a vital tool in in- 
forming our understanding of complex biological systems. A num- 
ber of mathematical models of the interactions between pathogens 
and host immune responses have been developed in recent years, 
https://doi.org/10.1016/j.jtbi.2020.110256 
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with bacterial pathogens studied including Mycobacterium tuber- 
culosis ( Marino and Kirschner, 2004 , Kischner and Marino, 2005 , 
Warrender et al., 2006 ), Bacillus anthracis ( Kumar et al., 2008 , 
Day et al., 2011 ) and Streptococcus pneumoniae ( Smith et al. , 
Mochan et al. ). In the context of macrophage function TB mod- 
els are particularly relevant. TB is an intracellular pathogen that 
requires a competent macrophage-mediated immunological re- 
sponse for effective control of mycobacterial growth. Modelling ap- 
proaches have shown that critical factors that influence pathogen 
growth include the recruitment and activation of macrophages, 
regulation of macrophage responses by cytokine signalling, and the 
recruitment of additional levels of the immune response that com- 
plement macrophage microbicidal strategies, such as T-cells and 
neutrophils ( Kischner and Marino, 2005 , Warrender et al., 2006 , 
Tattevin et al., 2009 ). This has further refined understanding of the 
important roles macrophages play in this infection. 
While there are a number of mathematical models address- 
ing the dynamics of other bacterial and viral infections there is 
not currently a mathematical model describing the macrophage 
response to S. aureus . In part, this is because there has never 
been an extensive study exploring the kinetics of phagocytosis 
or intracellular killing of S. aureus by differentiated macrophages 
that could be used to develop a model for S. aureus infection. 
We have recently performed this kinetic analysis using differen- 
tiated macrophages, with key findings validated in primary hu- 
man cells ( Jubrail et al., 2015 ), and now use this data to develop 
a novel mathematical model. The model describes the extracellu- 
lar and intracellular phases of S. aureus and their interaction with 
macrophages. These results provide important insights into how 
macrophages respond to S. aureus . 
2. Methods 
2.1. Experimental methods 
2.1.1. Macrophage phagocytosis 
Experimental data was obtained using a differentiated tissue 
macrophage cell line THP-1 exposed to the Newman strain of S. 
aureus ( Jubrail et al., 2015 ). Importantly the model uses a cell line 
whose differentiation status has been confirmed as replicating that 
of primary differentiated tissue macrophages ( Daigneault et al., 
2010 ) and findings have been validated in vitro with primary 
human monocyte-derived macrophages (hMDMs) and in vivo in 
murine alveolar macrophages. They have also been confirmed for 
the SH10 0 0 strain and for the USA300 JE2 strain, a representa- 
tive strain of community acquired MRSA, thus enhancing confi- 
dence in the broad relevance of the findings ( Jubrail et al., 2015 ). 
Live THP-1 differentiated macrophages and paraformaldehyde fixed 
macrophages were cultured with S aureus Newman strain at a 
range of MOIs (multiplicity of infection) for up to 9 hours. Alter- 
natively S. aureus Newman strain was cultured in the absence of 
macrophages for the same time course. At each time point, super- 
natants were plated onto blood agar for estimation of extracellular 
bacterial numbers using surface viability counts to determine the 
colony forming units (CFU). Extracellular bacteria were then killed 
with lysostaphin and cells lysed using 1% saponin to allow estima- 
tion of intracellular CFU ( Jubrail et al., 2015 ). 
2.1.2. Macrophage killing 
Macrophages were cultured with S aureus Newman strain at 
an MOI 5 for 6 hours and killing assays were performed as pre- 
viously described ( Jubrail et al., 2015 ). Extracellular bacteria were 
then killed with lysostaphin and some cultures treated with 1% 
saponin and lysed for intracellular CFU quantification. Remaining 
cultures were maintained in low dose lysostaphin for 0.5-4 hours 
and lysed at each time point for estimation of intracellular CFU. 
Results obtained with the high dose lysostaphin ‘pulse’ followed by 
the low dose lysostaphin ‘chase’ were verified using a similar ap- 
proach with antimicrobials that selectively target the extracellular 
population but not intracellular bacteria, using a protocol employ- 
ing gentamicin ‘pulse’ and vancomycin ‘chase’ to kill extracellular 
bacteria, to exclude any artefacts inherent in the use of lysostaphin 
( Jubrail et al., 2015 ). This data informs our selection of killing func- 
tions in the model, as described below. 
Data for extracellular and intracellular bacteria density is pre- 
sented for four different MOIs (0.05, 0.5, 1 and 5) with three repli- 
cates in each case. Active macrophage numbers (i.e. macrophages 
containing bacteria) are also plotted. These can be seen as the dots 
in Fig. 3 . Here, we note two key elements of the data that the 
model will need to capture. Firstly, the extracellular bacteria den- 
sities remain low at low MOIs for much longer than at high MOIs 
(note these plots show logged numbers, so this is not merely an 
artefact of exponential growth). Secondly, the intracellular num- 
bers appear to take-off at later time points at the higher MOIs but 
not the lower MOIs. 
2.2. Mathematical model 
We model the interaction between macrophages (with densi- 
ties, M i ) and S. aureus (with densities, S i ) using a set of ordinary 
differential equations as described below. We base the model on 
observations from the in vitro experiments and use this data to 
fit the model. We describe the model in detail below. There are 
similarities between our model and those of previous bacteria- 
cell studies (for example those of M. tuberculosis ( Marino and 
Kirschner, 2004 , Kischner and Marino, 2005 )), but here our model 
is set up to intentionally mimic our experimental results, since im- 
portant biological differences between M. tuberculosis and S. aureus 
are known, and as such there are a number of key differences to 
previous models. 
2.3. Macrophage cell dynamics 
We assume that initially all macrophages are in a resting state, 
M 0 , and that to become competent for phagocytosis they need to 
become activated. The rate at which these cells reach this thresh- 
old for activation is an increasing, saturating function of extracel- 
lular bacteria, S e , 
f ( S e ) = α
S p αe 
S p αe + c α
p α
(1) 
where c α is a threshold density at which the activation rate is α/2, 
and the power p α controls the shape of the function (c.f. Fig. 1 a). In 
particular, if p α = 1 then for low bacterial densities the increase in 
ingestion is linear (solid line, Fig. 1 a, inset), while for p α > 1 at low 
densities there is very little ingestion (dashed line, Fig. 1 a, inset) 
and for p α < 1 at low densities there is very high ingestion (dot- 
ted line, Fig. 1 a, inset). We refer to those functions where p α ≤ 1 
as ‘non-sigmoidal’, and those where p α > 1 as ‘sigmoidal’, due to 
their shapes (see Fig. 1 a). 
Activated cells become primed cells, M P , which are then able 
to ingest. The rate of ingestion is similarly given by an increasing, 
saturating function of extracellular bacteria, S e , 






e + c β
p β
(2) 
where c β gives the density of S e at which the ingestion rate is 
β
2 , and the power p β controls the shape of the function, in much 
the same way as the activation function above ( Fig. 1 a). Such a 
function has been used in the ecological literature for many years 
to represent predation, which is a similar process to ingestion 
here, as well as in previous bacteria-cell models (though these 
tend to assume p β = 1 ( Marino and Kirschner, 2004 , Kischner and 
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Fig. 1. Examples of the ingestion (A) and killing (B) functions for different values of p β and p k . In each case solid lines are for p i = 1 , dashed lines p i = 4 and dotted lines 
p i = 0 . 4 . The inset in panel A shows the shape of the ingestion functions at low bacterial densities (here the horizontal axis is on a linear scale). 
Marino, 2005 )) . Once cells have ingested bacteria we define them 
as active cells, M a , where they can continue to ingest. We do not 
differentiate between cells that have ingested but killed all of their 
bacteria and those that still contain viable bacteria. Functionally 
these cells behave the same, since we assume that once a cell in- 
gests it will continue to do so as long as there are extracellular 
bacteria. (As the experimental in vitro data is derived from a situa- 
tion where the extracellular bacteria out-compete the macrophage 
the situation where all bacteria are cleared is unlikely to arise.) In- 
deed, functionally the primed ( M p ) and active ( M a ) are very similar, 
but we require this differentiation both for the data fitting (since 
we only have data for active macrophages) and for certain imple- 
mentations of killing (see below). We note that since we assume 
no production or decay of macrophages, verified from the experi- 
mental data, the total cell population M̄ = 
∑ 
jǫ{ 0 ,p,a } M j is constant, 
meaning one of the equations can be neglected from the model. 
2.4. S . aureus dynamics 
Initially all bacteria are extracellular, S e , with replication rate r . 
We assume that there is some maximum density (carrying capac- 
ity), K , for the bacteria in the medium, with classical logistic (loga- 
rithmic) growth in the absence of macrophages. During model fit- 
ting, below, a generalized logistic model was also tested but the 
power was always predicted to be near to 1, suggesting the stan- 
dard logistic model is a reasonable parsimonious choice. Extracel- 
lular bacteria can be ingested by both primed and active cells. 
When first ingested the intra-cellular S. aureus are still vi- 
able as S i bacteria. The active cells then kill the bacteria through 
phagocytosis-associated killing mechanisms and the bacteria be- 
come killed, S k . However, based on observations with neutrophils 
that phagocytosis activates the nicotinamide adenine dinucleotide 
phosphate oxidase (NADPH oxidase/ NOX2) system which is linked 
to a number of microbicidal mechanisms of rapid bacterial killing 
( DeLeo et al., 1999 ), and our own observations of the kinetics of 
intracellular S. aureus killing in macrophages, which suggest there 
is a phase of rapid killing immediately after phagocytosis followed 
by a gradual rate of later decline in bacterial viability ( Jubrail et al., 
2015 ), we assume that the ability of cells to kill the intra-cellular 
bacteria is lost over time. The cause of this loss in killing is not 
clear, but is likely due to exhausting a combination of bioenergetic 
demands (phagocytosis, killing, etc). Here we compare three dif- 
ferent model assumptions. In model 1 we assume that the loss is 
strictly due to macrophages using up key resources during phago- 
cytosis. In this case the rate of killing is a decreasing function of 
the average number of both viable and non-viable intra-cellular 
bacteria per active cell, ( S i + S k ) / M a . In model 2 we assume that 
the loss is due to using up resources during killing, meaning the 
rate of killing is a decreasing function of the average number of 
only non-viable intra-cellular bacteria per active cell (i.e., those 
killed), S k / M a . Finally in model 3 we assume that the loss is due 
to the down-regulation of killing by macrophages as the infection 
density increases (for example, to maintain resources for phago- 
cytosis). In this case we assume that killing is a decreasing func- 
tion of the extra-cellular bacteria density, S e . As we say, in reality 
we expect a combination of these processes is involved, but these 
model assumptions may guide us in which processes are key. For 
each assumption, this equation can be given by, 
h ( X ) = k 
(
1 −
X p k 




where X ∈ [ ( S i + S k ) / M a , 
S k 
M a 
, S e ] depending on the model ( Fig. 1 b). 
If p k = 1 , the initial drop in killing is linear with S. aureus density. 
If p k > 1, killing initially remains high before a threshold effect 
and a sharp drop in killing. If p k < 1, then killing drops off quickly 
before saturating. 
The full system of equations is given below. See Table 2 for a 
list of parameter definitions and a schematic of the model in ESM. 
d M P 
dt 
= αM 0 
(
S p αe 
S p αe + c α
p α
)
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dt 
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e + c β
p β
)
− k S i 
(
1 −
X p k 




d S k 
dt 
= k S i 
(
1 −
X p k 




2.5. Model Fitting 
The model is fitted to the experimental data using a 
rejection Approximate Bayesian Computation (ABC) approach 
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Table 1 
Details of model fitting from 10,0 0 0 runs with parameter values chosen from uniform distribu- 
tions with maximum and minimum values as shown by the histograms in Fig. 2 . This shows 
the minimum sum-of-squared error returned under each killing assumption, and the numbers 
of runs under certain error thresholds. 
Killing assumption Min. ǫ Runs with ǫ < 8 Runs with ǫ < 9 Runs with ǫ < 10 
Model 3 S e 6.639 27 141 388 
Model 2 S k / M a 7.761 4 85 284 
Model 1 ( S i + S k ) / M a 8.388 0 3 11 
Table 2 
Parameter descriptions, their mean values from model fitting with ε = 9 and the range of values in 
the uniform prior distribution. 
Parameter Definition Mean posterior value Prior range 
α Basic priming rate of M 0 cells 12.229 0.5-25 
c α Threshold density of priming function 2.223 × 10 4 10 2 − 10 6 
p α Power (slope) of priming function 4.708 0-10 
β Basic ingestion rate of cells 3.232 0.5-8.5 
c β Threshold density of ingestion function 3.776 × 10 
8 10 2 . 5 − 10 9 . 5 
p β Power (slope) of ingestion function 0.557 0-2 
r Basic growth rate of S e bacteria 0.571 0.4-0.8 
k Basic killing rate of cells 13.685 0-20 
c k Threshold density of killing function 2.159 × 10 
7 10 5 . 5 − 10 8 . 5 
p k Power (slope) of killing function 4.934 0-10 
Beaumont, 2010 , Csill éry et al., 2010 ). Such a Bayesian approach is 
advantageous since it incorporates variation/uncertainty in the pa- 
rameter estimates. Given that the experimental data itself reveals 
variation of as much as an order of 10, accounting for this varia- 
tion is clearly important. Values for each parameter in the model 
are randomly sampled from uniform prior distributions with de- 
fined upper and lower limits chosen after preliminary runs. The 
model is then run using the ode45 solver in MATLAB and the sum 
of squares error calculated between the logged model output and 
logged data, summed over the intra- and extra-cellular densities at 
the four MOIs. Macrophage data is not included in the model fit- 
ting as it was gathered from a separate experiment, but is used as 
a comparison of models at a later stage. If the error is less than 
some chosen value, ɛ , the parameter set is accepted and stored, 
if it is greater than the value it is rejected. As ɛ becomes smaller 
the parameters should approach the ‘true’ values. 10 0,0 0 0 runs are 
performed for each model. This results in posterior distributions 
for every parameter of those sets kept for each model. Compar- 
isons of the three models tested (where limitation in killing de- 
pends on ((1) average number of bacteria ingested, (2) average 
number of bacteria killed or (3) extracellular bacteria densities) are 
performed firstly by computing Bayes factors given by the ratio of 
acceptance rates for a given ɛ , and secondly by computing Akaike 
Information Criteria (AIC) for the (mean) least-squares error when 
fitted against the macrophage data. 
An additional model assumption was tested in which for the 
first half hour there is neither bacterial growth nor ingestion, but 
this was found to produce relatively poor model fits. 
3. Results 
Table 1 presents a comparison of the performance of the three 
model variants tested (see Table 2 for the maxima and minima of 
the uniform priors). It is immediately clear that the least success- 
ful model is model 1 (killing is a function of the average number 
of bacteria ingested, ( S i + S k ) / M a ), with both a much higher min- 
imum error and far fewer numbers of runs falling below arbitrar- 
ily chosen cut-offs than the other two models. Of the remaining 
assumptions, model 3 (killing is limited by extracellular density, 
S e ) receives the stronger support. Comparing model 3 with model 
2 (limitation through number of bacteria killed) the Bayes factor 
for the given values of epsilon are 6.75 ( ε = 8) , 1.66 ( ε = 9) and 
1.37 ( ε = 10) . This indicates some positive, but not strong, support 
for selecting the model with limitation due to extracellular bacte- 
ria over the model with limitation due to killed bacteria ( Kass and 
Raftery, 1995 ), with increasing support as the threshold for accep- 
tance is reduced. Further investigation revealed some sensitivity to 
the chosen bounds of the priors, in particular the rate of prim- 
ing, α. When this is constrained to a lower maximum the Bayes 
factor for model 3 vs model 2 improves dramatically due to re- 
duced success of model 2 (with a maximum of α= 10 the accep- 
tances for ε = 9 become 128 and 5 respectively, giving a Bayes fac- 
tor of 25.6, indicating strong support for model 3). Additionally we 
compared the performance of each of these two models at fitting 
the as-yet unfitted macrophage data. Running 100 simulations with 
all parameter values chosen from the accepted posterior distribu- 
tions ( ε = 9) of the two models, the average sum of squares er- 
ror for model 3 is 51.14 and for model 2 is 104.12. Treating these 
averages as model runs, this yields a relative AIC (7 data points 
and 10 parameters) for model 2 of 0.08, again indicating reason- 
able but not overwhelming support for model 3 as the better fit. 
We suggest this unintuitive result indicates that killing is limited 
by a combination of bioenergetic processes, and that the extracel- 
lular density is providing the best ‘snapshot’ of the demands on 
the macrophages, with the non-negligible support for the limita- 
tion by killing model suggesting this may be a key process. For 
the remainder of the study we focus on the model with limitation 
through extracellular density. 
Fig. 2 shows the posterior distributions of the parameter values 
for the model with killing linked to extracellular density where ε = 
9 . Note that the three threshold densities are plotted as logarithms. 
A number of the parameters present as normal distributions (par- 
ticularly p β , r , c k ), and others with clear indications that the param- 
eter is ‘low’ or ‘high’ (e.g. c α , β , c β , k ), giving us some confidence in 
the value of these parameters and their importance for the model. 
Other parameters yield rather uninformative posterior distribu- 
tions, for example the power in the killing function, p k , is likely 
to be greater than 1 (and is thus sigmoidal) but could take almost 
any positive value and still return good fits. In contrast it is notable 
that the power in the ingestion function, p β , is very likely to be 
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Fig. 2. Posterior distributions for parameters in Eqs. (4)–(8) from Approximate Bayesian Computation, with a sum of squares error threshold of 9 after 10 0,0 0 0 model runs. 
For each parameter 10 equally sized bins between the minimum and maximum of the uniform priors are used. 
less than one and thus non-sigmoidal. This provides a clear con- 
trast to many previous models of bacteria-cell dynamics that as- 
sume a power of unity ( Marino and Kirschner, 2004 , Kischner and 
Marino, 2005 ). Also, the threshold density for priming, c α , appears 
to be less than 10 5 , potentially with a high saturation constant, p α , 
suggesting that at very low MOIs few macrophages are primed at 
early time points, but at higher MOIs priming in response to bac- 
teria happens rapidly. 
Fig. 3 plots the experimental data (circles for fitted data, crosses 
for unfitted data) against 100 runs where two parameters – the 
threshold values for ingestion, c β , and killing, c k – were drawn at 
random from the posterior distribution (grey lines) and all other 
parameters took the mean posterior value (see Fig. 2 and Table 2 ). 
One run using the mean values for all parameters from the poste- 
rior distributions is also highlighted (black line) (we acknowledge 
that the mean value is not necessarily representative of certain 
parameter values, but is a parsimonious choice for producing in- 
dicative results). Focusing on the mean (black solid line), the fit 
against the data is reasonable with two clear discrepancies: under- 
prediction of the number of intracellular bacteria at the lowest 
MOI, and a later acceleration of intracellular bacteria at the highest 
MOI. However, varying just the two parameters appears to account 
for almost all of the variation in the data, and in particular demon- 
strates the relatively slow extracellular dynamics at low MOIs and 
the take-off of intracellular numbers at the highest MOI. These two 
parameters, c β and c k were chosen as parameters that are unlikely 
to have ‘pre-determined’ fixed values and variability should be ex- 
pected. Fig. 4 a again shows 100 simulation runs but now with all 
parameters drawn from the posterior distribution, and now cover- 
ing all variation in the data. Overall we suggest that there is some 
variability in many of the biological processes, and especially the 
ingestion and killing thresholds. Indeed, it is noticeable that we 
see variation within the three experimental data replicates in each 
MOI, especially at the higher doses. The existence of this variability 
lends weight to our selection of a Bayesian model fitting routine, 
which inherently captures the heterogeneity. 
We conduct predictive checks of the model under both the 
prior and posterior parameter distributions to consider how well 
the fitted model is capturing the data ( Maclaren et al., 2017 ). 
Fig. 4 b is identical in its production to Fig. 4 a except that here 
we have used the prior distributions for the parameter values. It is 
clear graphically that the fitted model performs significantly bet- 
ter at capturing the data. Moreover we can again use the unfitted 
macrophage data as an additional data set to measure the least- 
squares error as 100 full sets of parameter values are drawn at 
random from the posterior and prior distributions. Above we had 
found the posterior error had a mean of 51.14. For the prior distri- 
bution the mean error is 166.84, leading to a relative AIC of 0.016. 
Again, this gives a clear indication that the fitted model is better 
capturing the behavior of the data. 
3.1. Mathematical analysis 
We now perform a more formal mathematical analysis, in- 
formed by the model fitting above, to explore the system’s be- 
haviour. In particular, the behavior of the system (4) –(8) depends 
critically on the form of the ingestion function with different qual- 
itative outcomes for non-sigmoidal and sigmoidal functions. Given 
the clear prediction that ingestion is non-sigmoidal ( p β ≤ 1) from 
the model fitting, we focus only on this case. 
Eqs. (4) –(6) for the macrophage and extracellular bacteria den- 
sities form a closed system that can be solved. For non-sigmoidal 
ingestion there are two biologically-relevant (that can be both 
stable and positive) equilibria. The first is an infection-free case 
( S e = 0 , M p = Y − X, M a = X) where the macrophages have suc- 
cessfully eradicated the infection, taking X active cells to do so 
(with M 0 = M̄ − Y un-primed cells remaining). Since there are no 
extracellular bacteria we would also expect the intracellular num- 
bers to eventually decrease to zero, though this may be a very slow 
process if the intra-cellular densities had got too high before the 
infection was eradicated. For the special case of p β = 1 this equi- 
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Fig. 3. Experimental data (circles for bacteria data, crosses for macrophage data) and mathematical model fits for four MOIs. In each case the x-axis represents time in 
hours, and the y-axes are the log-10 densities. The black solid line gives the mean values from the posterior distributions in Fig. 2 . The grey lines show 100 runs with the 
threshold values for ingestion, c β , and killing, c k chosen from the respective posterior distributions. 
Fig. 4. Similarly to Fig. 3 , experimental data (circles for bacteria data, crosses for macrophage data) and mathematical model fits for four MOIs. In (a) all parameters are 
drawn from the posterior distributions in Fig. 2 . In (b) all parameters are drawn from the prior distributions as in Table 2 . 





in other words when the growth rate of the bacteria is lower than 
the ingestion rate of the macrophages at low bacteria densities. 
Based on the parameter estimates above this would require very 
high cell densities (~10 7 ) to be possible. More generally, for p β < 1, 
the infection-free equilibrium is always locally stable since at very 
low bacterial densities we always have d S e 
dt 
< 0 due to the relatively 
high ingestion rates at low bacterial densities, though the basin 
of attraction (in terms of S e densities) for this equilibrium shrinks 
rapidly as M̄ → 0 (see Fig. 6 below). 
The second case is an endemic quasi-equilibrium, 
which for the special case of p β = 1 occurs at ( S e = 
( K − c β + 
√ 
( K + c β ) 
2 
− 4 K M r ) / 2 , M p = 0 , M a = M̄ ). The case 
when p β < 1 will be qualitatively similar (as can be seen by 
plotting the two terms of equation (6) and considering how the 
two curves will cross). Here all macrophages contain bacteria and 
the extracellular numbers have settled to an equilibrium that is 
a small amount below their carrying capacity. The percentage 
reduction is proportional to 
√ 
M̄ /K , which would mean a very 
small reduction given the densities used in the accompanying 
experimental work ( 
√ 
10 5 / 10 9 = 1% reduction from K ). While this 
final reduction may be minimal, the impact of the macrophages 
on the initial growth is starkly illustrated by considering the 
per-capita growth rate of extracellular bacteria in equation (6) . 
This is given by, 

















Under the assumption that all macrophages are primed (such 
that M P + M a = M̄ ) , we can compare the case where p β = 1 
(dashed) with the mean value predicted from the model fitting 
p β = 0 . 557 (solid) in Fig. 5 . It is striking that at lower bacterial 
densities, under the predicted shape of the ingestion function, g ( S e ) 
( equation (2) ), the macrophages’ response have a considerable im- 
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Fig. 5. The per-capita growth rate, ρ , Eq. (9) , of extracellular bacteria, with values set as the mean from the posterior distributions in Fig. 2 . In particular p β = 0 . 557 (solid 
line). For comparison p β = 1 (dashed) is also shown. 
pact on extracellular growth, thus causing a significant delay in the 
bacteria approaching its final density. 
We term this second case considered above a quasi-equilibrium 
since the number of intracellular bacteria will in fact continue to 
increase by Eq. (7) . The quasi-equilibrium only exists up to a cer- 
tain value of M̄ , and for higher values only the infection-free state 
is feasible. However, even for lower values of M̄ , where both equi- 
libria are feasible, there is a region of bistability in the system as 
the stability condition is distinct from that of the infection-free 
case, which for the special case of p β = 1 is given by, 
r > 
βM̄ c βK 
(
S ∗e + c β
)2 
( K − 2 S ∗e ) 
. 
For the more general case of p β < 1, as we have noted, the 
infection-free equilibrium is always locally stable, and this bistabil- 
ity exists for the whole range of M̄ for which the endemic quasi- 
equilbirium is feasible. This can be seen clearly by plotting the 
equilibrium values for S e as the total cell density is varied as in 
Fig. 6 (using the mean parameter values from the posterior distri- 
butions in Fig. 1 ). At low values of M̄ the basin of attraction for 
the endemic quasi-equilibrium is very large and even small doses 
of bacteria will grow to close to the carrying capacity. Indeed, for 
the population sizes used here (10 5 ), a bacterial dose of 100 (i.e. 
an MOI of 0.001) would see the bacteria grow. For very high val- 
ues of M̄ the bacteria will always be eradicated. For intermediate 
densities, however, the outcome depends on the initial density of 
bacteria, with full control possible for realistic S. aureus doses if 
the macrophage population is large enough. 
4. Discussion 
We find that at low doses of S. aureus infection macrophages 
delay exponential growth of the bacteria for a number of hours, 
buying the host time to recruit other inflammatory cells to con- 
trol infection. At higher doses the response can be overwhelmed 
such that there is almost no control. We identified bistabilities in 
Fig. 6. – Location and stability of extracellular bacteria equilibria for varying 
macrophage numbers, M̄ . Solid line gives the stable equilibrium, the dashed line 
the unstable equilibrium. Arrows show the basin of attraction. Parameter values are 
the means of the posterior distributions in Fig. 2 as given in Table 2 . 
the system such that a large and fast enough macrophage response 
may be able to significantly limit the final size of the infection pro- 
vided the dose is low. We also found that killing is the key lim- 
iting step in the macrophage response to all infections, but that 
ingestion fails to keep pace with bacterial growth at high bacte- 
rial densities. Our model provides a good fit to experimental data 
and provides important insights into the early course of S. aureus 
infections. 
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Previously there has not been robust experimental kinetic data 
involving differentiated macrophages on which to base model pa- 
rameters. A great strength of this model is that it is informed 
by data with a differentiated macrophage cell line that replicates 
the phagocytic and microbicidal response of differentiated tissue 
macrophages ( Daigneault et al., 2010 ). Moreover the experimental 
data has been validated for primary human macrophages and in 
the clinically relevant JE2 strain ( Jubrail et al., 2015 ). This makes 
the data relevant to major clinical strains that are highly prevalent, 
such as USA300. These play a major role in current community- 
acquired MRSA infections and are a major cause of skin and soft 
tissue infection ( DeLeo et al., 1999 ). Based on this experimen- 
tal data our model has shown that macrophages may not fully 
clear an S. aureus infection even at relatively low initial doses. The 
growth rate of the bacteria generally outstrips the ingestion rate 
of the macrophages for parameter values estimated from experi- 
mental data. The macrophage response will reduce the final size 
of the extracellular bacterial population, but only by a small per- 
centage. However, we do see that at low doses the macrophages 
are able to delay exponential growth of the bacteria for a number 
of hours due to the relatively high ingestion rate at low bacterial 
densities. In vivo this may allow the immune system to ‘buy time’ 
while further immune cells, including neutrophils and T-cells, are 
recruited to the site of infection. This extended control of infec- 
tion at lower doses could activate downstream signalling pathways 
in active macrophages leading to the recrutiment of monocytes 
and/or other immune cells to further help with infection control. 
Macrophages play important roles generating the cytokine net- 
works required to recruit other immune cells during the immune 
response to Gram-positive bacteria such as S. aureus ( Cole et al., 
2014 ), so the extra time they buy during infection may be highly 
relevant for infection outcome. A clear area for future modelling is 
to incorporate the recruitment of such cells to give a more realistic 
model of an in vivo infection, similarly to models of Mycobacterium 
( Kischner and Marino, 2005 ) and Streptococcus ( Smith et al. ). 
It is clear from our results that the killing ability of 
macrophages is finite and becomes overwhelmed with sustained 
killing. Interestingly, our Bayesian model fitting indicates that this 
limitation may be linked to the extracellular bacteria density. We 
suggest this result reflects that it is not individual processes re- 
lated to intracellular numbers, such as ingestion or killing, but 
the cumulative effect of all of these that limits clearance. It may 
be that extracellular numbers are a better surrogate for the over- 
all effect of intracellular burden since measures of viable or non- 
viable bacteria intracellularly represent only a ‘snapshot’ of over- 
all interacellular burden and clearance. What is clear, however, 
is that after macrophages have been actively tackling relatively 
low numbers of bacteria the killing rate shows a significant drop- 
off to a state of almost no further killing. This fits with current 
knowledge from experimental studies of this system that loss of 
killing is a significant limiting step in macrophages’ response to 
S. aureus infection ( Jubrail et al., 2015 ). Stimulating macrophages 
with the M1 cytokine interferon gamma (IFN γ ) only modestly 
improved intracellular killing suggesting that failure of classical 
macrophage activation was not responsible and intracellular killing 
capabilities had been overwhelmed irrespective of classical activa- 
tion ( Jubrail et al., 2015 ). The ingestion ability of macrophages, on 
the contrary, showed no evidence of a decline, but the rate of in- 
gestion did saturate at medium bacteria densities since cells can- 
not physically ingest more than a set number of bacteria in a cer- 
tain time. Thus our model identifies that ingestion by macrophages 
is also an important limiting step as the size of infection grows. 
However, at low bacteria densities the model fitting suggests 
that the macrophages are rather efficient at ingesting and that 
full eradication of moderate inocula would be possible for large 
enough macrophage numbers. This emphasises the importance of 
the macrophage response being launched before the infection has 
grown too large. It would be interesting to consider the extent to 
which such dose-dependent responses are seen in other pathogens. 
While we have based our model on in vitro experimental re- 
sults, our model has suggested that complete eradication of low 
dose infections would be possible if far more macrophages were 
added, provided they were in the optimal polarisation status. This 
would have the effect of increasing the ingestion rate of the 
macrophage population. While this was not tested in our experi- 
mental set-up, in vivo it may be possible if recruitment of addi- 
tional monocytes is fast enough. Monocytes have been shown to 
contribute to control of S. aureus in animal models ( Veltrop et al., 
20 0 0 ) and recruitment of monocytes from the blood into the tis- 
sues and subsequent differentiation into macrophages could be 
beneficial for pathogen control. There is also evidence of local pro- 
liferation of alternatively activated macrophages within tissues un- 
der conditions where Th2 cytokines dominate ( Jenkins et al., 2011 , 
Jenkins et al., 2013 ), as would occur during conditions such as 
eczema and atopic dermatitis, that are associated with S. aureus 
colonisation ( Gong et al., 2006 ). Thus one can envisage clinical sce- 
narios where macrophage numbers responding to S. aureus could 
be supplemented either from monocyte-derived or tissue-derived 
populations to help control infection. However, it reamins unclear 
whether these alternative sources would enhance clearance or pro- 
vide extra cells in which ingestion might promote a population 
of viable intracellular opulation of bacteria since ingestion with- 
out complete killing can favour escape from macrophage host de- 
fence by Gram-positive bacteria, as recently demonstrated for sub- 
populations of splenic macrophages that fail to clear ingested S. 
pneumoniae , promoting sepsis ( Ercoli et al., 2018 ). Therefore the 
number of ‘active’ macrophages is likely to be a critical determi- 
nant of outcome. In this respect an increase in numbers of ‘ac- 
tive’ macrophages and the ability to prime cells for this function 
is likely to vary between individuals explaining some of the vari- 
ation in ability to handle bacteria observed. This would be more 
likely than altering numbers of tissue macrophages at the site of 
infection in the initial period .With the exception of clinical stiu- 
ations such as radiation or inhalation of toxic fumes variation in 
tissue macrophage numbers is less likely to vary than the qualita- 
tive function of these cells ( Cole et al., 2014 ). 
An important finding from the model is that there is bistability 
between different states. This means that infections at low doses 
are much more easily controlled than those at high doses, high- 
lighting the importance of a fast immune response to S. aureus 
infection. Moreover, the bistability means that simply calculating 
an “R 0 -like” bacteria-free stability condition is not enough to en- 
sure control, and if the immune response, or indeed treatment, is 
delayed then control of the infection is much harder. An implica- 
tion of this is that if the immune competence of the macrophage 
is altered control of S. aureus may be less successful. An exam- 
ple of this clinically could be the observation that S. aureus skin 
infections with virulent MRSA strains are more frequently encoun- 
tered in people living with HIV infection ( Popovich et al., 2010 ), a 
setting where macrophage function is altered ( Collini et al., 2010 ). 
Variation in numbers of ‘active’ macrophages represents a plausible 
explanation to how the the bistability in the model we observed 
could lead to variation in disease outcome between patient groups. 
The model fitting highlighted that there appears to be some 
variation in a number of the mechanistic rates, as a single param- 
eter set failed to fit all of the experimental data well simultane- 
ously, particularly of the timing of sudden increases in intracellu- 
lar bacteria. Our approach of using Approximate Bayesian Compu- 
tation allowed us to overcome this by including variability in the 
parameter estimates. In particular, allowing variation in the param- 
eter values for the killing and ingestion thresholds allowed most 
of the variation in the data to be predicted, suggesting that these 
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processes may not be homogenous or some biologically relevant 
terms may be missing from the model. As well as the future ex- 
tensions already mentioned above, it may therefore also be im- 
portant to explore the impact of macrophage heterogeneity. Tis- 
sue heterogeneity in macrophage populations is increasingly recog- 
nised both in terms of the variation between tissues ( Gordon et al., 
2014 ) and the range of phenotypes within a tissue ( Laskin et al., 
2001 ) and future work should explore this. There could also be sig- 
nalling between macrophages allowing an exhausted macrophage 
to elicit a signal to a nearby macrophage which can pick up the 
released bacteria. The concept of direct and indirect paracrine ef- 
fects in response to a pathogen are well characterized in infectious 
diseases and can be transmitted by cytokines or other signaling 
peptides produced by the host cells ( Mosser and Edwards, 2010 ). 
These cytokine responses lead to paracrine effects on neighbour- 
ing cells that can enhance pathogen clearance. Again, models of 
other bacteria-cell interactions have included cytokine signaling 
( Kischner and Marino, 2005 , Smith et al .) and would be an im- 
portant extension to explore here. 
In conclusion, we have shown that based on unique experimen- 
tal data we do not expect macrophages to completely eradicate 
S. aureus infections on their own except at very low inocula, but 
that they will delay the exponential growth phase, buying time 
for recruitment of further immune cells. In addition supplement- 
ing numbers of activated macrophages can further enhance the 
macrophages’ contribution to the immune response and clearance 
of S. aureus . Thus despite S. aureus ability to subvert macrophage 
innate responses macrophages still make a major contribution to 
host defense against this pathogen. 
Author Contributions 
AB helped design the study, carried out the mathematical anal- 
syis and model fitting and drafted the manuscript; JJ carried out 
the experimental work, helped with the mathematical analysis 
and helped draft the manuscript; MB conceived of the study and 
helped draft the manuscript; DD conceived of the study, helped 
design the study and helped draft the manuscript; HM conceived 
of the study, helped design the study, helped carry out the experi- 
mental work and helped draft the manuscript. 
Data 
The data is available from chapter 3 on the thesis found at http: 
//etheses.whiterose.ac.uk/id/eprint/6636 . 
Declaration of Competing Interest 
We have no competing interests. 
Acknowledgements 
AB was supported by a Leverhulme Trust UK Fellowship 
ECR2013-117. HM was supported by an MRC grant G0902354. This 
work has also been supported by the MRC AMR SHIELD consortium 
MR/N02995X/1. 
Supplementary materials 
Supplementary material associated with this article can be 
found, in the online version, at doi: 10.1016/j.jtbi.2020.110256 . 
References 
Beaumont, M.A. , 2010. Approximate Bayesian computation inevolution and ecology. 
Annu. Rev. Ecol. Evol. S. 41, 379–406 . 
Cole, J , Aberdein, J , Jubrail, J , Dockrell, DH , 2014. The role of macrophages in the 
innate immune response to Streptococcus pneumoniae and Staphylococcus aueus : 
mechanisms and contrasts. Adv. Microb. Phys. 65, 125–202 l . 
Cole, J, Aberdein, J, Jubrail, J, Dockrell, DH, 2014. The role of macrophages in 
the innate immune response to Streptococcus pneumoniae and Staphylo- 
coccus aureus: mechanisms and contrasts. Advances in microbial physiology 
65, 125–202. doi: 10.1016/bs.ampbs.2014.08.004 , Epub 2014/12/06PubMed PMID: 
25476766. 
Collini, P , Noursadeghi, M , Sabroe, I , Miller, RF , Dockrell, DH , 2010. Monocyte and 
macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate im- 
munity. Current molecular medicine 10 (8), 727–740 Epub 2010/10/13. PubMed 
PMID:20937022 . 
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